In collaboration with Memorial Sloan Kettering Cancer Center
with support from:
Amgen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Pfizer, Takeda Oncology, The Binding Site
The IMF M-Power Initiative is focused on changing the course of myeloma in the African-American community. Myeloma is two times as common in people of African descent as it is in all other races and ethnicities. Empower yourself by joining our 1st virtual M-Power New York webinar, held in collaboration with Memorial Sloan Kettering Cancer Center.
Event panelists include Dr. Saad Usmani (Memorial Sloan Kettering - NYC); IMF Nurse Leadership Board Member Amy E. Pierre, RN, MSN, ANP-BC; and IMF Chief Medical Officer Dr. Joseph Mikhael. Panelists will be participating in real time and answering your questions.
In collaboration with Memorial Sloan Kettering Cancer Center
with support from:
Amgen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm Therapeutics, Pfizer, Takeda Oncology, The Binding Site